Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.

Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT.

Neuropsychopharmacology. 2018 Nov;43(12):2399-2407. doi: 10.1038/s41386-018-0209-3. Epub 2018 Sep 10.

PMID:
30305739
2.

Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.

Gannon BM, Mesmin MP, Sulima A, Rice KC, Collins GT.

Psychopharmacology (Berl). 2018 Sep 29. doi: 10.1007/s00213-018-5046-x. [Epub ahead of print]

PMID:
30267131
3.

Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.

Collins GT, France CP.

Exp Clin Psychopharmacol. 2018 Oct;26(5):488-496. doi: 10.1037/pha0000209. Epub 2018 Jun 28.

PMID:
29952618
4.

The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders.

Collins GT, Gerak LR, France CP.

Neuropharmacology. 2017 Dec 12. pii: S0028-3908(17)30620-2. doi: 10.1016/j.neuropharm.2017.12.023. [Epub ahead of print] Review.

PMID:
29246856
5.

Inhibition of Cocaine and 3,4-Methylenedioxypyrovalerone (MDPV) Self-Administration by Lorcaserin Is Mediated by 5-HT2C Receptors in Rats.

Gannon BM, Sulima A, Rice KC, Collins GT.

J Pharmacol Exp Ther. 2018 Mar;364(2):359-366. doi: 10.1124/jpet.117.246082. Epub 2017 Dec 7.

6.

Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.

Gannon BM, Galindo KI, Mesmin MP, Sulima A, Rice KC, Collins GT.

Neuropharmacology. 2018 May 15;134(Pt A):28-35. doi: 10.1016/j.neuropharm.2017.08.018. Epub 2017 Aug 12.

PMID:
28811192
7.

Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.

Gannon BM, Galindo KI, Mesmin MP, Rice KC, Collins GT.

Neuropsychopharmacology. 2018 Mar;43(4):761-769. doi: 10.1038/npp.2017.141. Epub 2017 Jul 5.

PMID:
28677665
8.

Reinforcing effects of abused 'bath salts' constituents 3,4-methylenedioxypyrovalerone and α-pyrrolidinopentiophenone and their enantiomers.

Gannon BM, Rice KC, Collins GT.

Behav Pharmacol. 2017 Oct;28(7):578-581. doi: 10.1097/FBP.0000000000000315.

9.

Selective Pharmacological Augmentation of Hippocampal Activity Produces a Sustained Antidepressant-Like Response without Abuse-Related or Psychotomimetic Effects.

Carreno FR, Collins GT, Frazer A, Lodge DJ.

Int J Neuropsychopharmacol. 2017 Jun 1;20(6):504-509. doi: 10.1093/ijnp/pyx003.

10.

Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.

Gannon BM, Galindo KI, Rice KC, Collins GT.

J Pharmacol Exp Ther. 2017 Apr;361(1):181-189. doi: 10.1124/jpet.116.239376. Epub 2017 Feb 8.

11.
12.

Discriminative Stimulus Effects of Binary Drug Mixtures: Studies with Cocaine, MDPV, and Caffeine.

Collins GT, Abbott M, Galindo K, Rush EL, Rice KC, France CP.

J Pharmacol Exp Ther. 2016 Oct;359(1):1-10. doi: 10.1124/jpet.116.234252. Epub 2016 Aug 4.

13.

Determinants of conditioned reinforcing effectiveness: Dopamine D2-like receptor agonist-stimulated responding for cocaine-associated stimuli.

Collins GT, France CP.

Eur J Pharmacol. 2015 Dec 15;769:242-9. doi: 10.1016/j.ejphar.2015.11.024. Epub 2015 Nov 21.

14.

Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys.

Collins GT, Gerak LR, Javors MA, France CP.

J Pharmacol Exp Ther. 2016 Jan;356(1):85-95. doi: 10.1124/jpet.115.228833. Epub 2015 Nov 3.

15.

Effects of consuming a diet high in fat and/or sugar on the locomotor effects of acute and repeated cocaine in male and female C57BL/6J mice.

Collins GT, Chen Y, Tschumi C, Rush EL, Mensah A, Koek W, France CP.

Exp Clin Psychopharmacol. 2015 Aug;23(4):228-37. doi: 10.1037/pha0000019.

17.

Effects of dopamine D(2)-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition.

Collins GT, Jackson JA, Koek W, France CP.

Eur J Pharmacol. 2014 Apr 15;729:123-31. doi: 10.1016/j.ejphar.2014.02.014. Epub 2014 Feb 20.

18.

Nicotine-like behavioral effects of the minor tobacco alkaloids nornicotine, anabasine, and anatabine in male rodents.

Caine SB, Collins GT, Thomsen M, Wright C, Lanier RK, Mello NK.

Exp Clin Psychopharmacol. 2014 Feb;22(1):9-22. doi: 10.1037/a0035749.

PMID:
24490708
19.

Cocaine self-administration in dopamine D₃ receptor knockout mice.

Caine SB, Thomsen M, Barrett AC, Collins GT, Grundt P, Newman AH, Butler P, Xu M.

Exp Clin Psychopharmacol. 2012 Oct;20(5):352-63. doi: 10.1037/a0029135. Epub 2012 Aug 6.

20.

Self-administration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys.

Koffarnus MN, Collins GT, Rice KC, Chen J, Woods JH, Winger G.

Behav Pharmacol. 2012 Aug;23(4):331-8. doi: 10.1097/FBP.0b013e3283564dbb.

21.

Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Collins GT, Brim RL, Noon KR, Narasimhan D, Lukacs NW, Sunahara RK, Woods JH, Ko MC.

J Pharmacol Exp Ther. 2012 Jul;342(1):205-13. doi: 10.1124/jpet.112.194639. Epub 2012 Apr 19.

22.

Lack of abuse potential in a highly selective dopamine D3 agonist, PF-592,379, in drug self-administration and drug discrimination in rats.

Collins GT, Butler P, Wayman C, Ratcliffe S, Gupta P, Oberhofer G, Caine SB.

Behav Pharmacol. 2012 Jun;23(3):280-91. doi: 10.1097/FBP.0b013e3283536d21.

23.

CJ-1639: A Potent and Highly Selective Dopamine D3 Receptor Full Agonist.

Chen J, Collins GT, Levant B, Woods J, Deschamps JR, Wang S.

ACS Med Chem Lett. 2011 Aug 11;2(8):620-625.

24.

Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats.

Collins GT, Narasimhan D, Cunningham AR, Zaks ME, Nichols J, Ko MC, Sunahara RK, Woods JH.

Neuropsychopharmacology. 2012 Apr;37(5):1092-103. doi: 10.1038/npp.2011.226. Epub 2011 Oct 12.

25.

The fate of bacterial cocaine esterase (CocE): an in vivo study of CocE-mediated cocaine hydrolysis, CocE pharmacokinetics, and CocE elimination.

Brim RL, Noon KR, Collins GT, Stein A, Nichols J, Narasimhan D, Ko MC, Woods JH, Sunahara RK.

J Pharmacol Exp Ther. 2012 Jan;340(1):83-95. doi: 10.1124/jpet.111.186049. Epub 2011 Oct 11.

26.

Subunit stabilization and polyethylene glycolation of cocaine esterase improves in vivo residence time.

Narasimhan D, Collins GT, Nance MR, Nichols J, Edwald E, Chan J, Ko MC, Woods JH, Tesmer JJ, Sunahara RK.

Mol Pharmacol. 2011 Dec;80(6):1056-65. doi: 10.1124/mol.111.074997. Epub 2011 Sep 2.

27.

The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometry.

Brim RL, Noon KR, Collins GT, Nichols J, Narasimhan D, Sunahara RK, Woods JH.

Mol Pharmacol. 2011 Dec;80(6):1119-27. doi: 10.1124/mol.111.074534. Epub 2011 Sep 1.

28.

Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats.

Collins GT, Cunningham AR, Chen J, Wang S, Newman AH, Woods JH.

Psychopharmacology (Berl). 2012 Jan;219(1):123-35. doi: 10.1007/s00213-011-2382-5. Epub 2011 Jun 24.

29.

Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.

Collins GT, Zaks ME, Cunningham AR, St Clair C, Nichols J, Narasimhan D, Ko MC, Sunahara RK, Woods JH.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):158-65. doi: 10.1016/j.drugalcdep.2011.03.015. Epub 2011 Apr 11.

30.

Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.

Collins GT, Carey KA, Narasimhan D, Nichols J, Berlin AA, Lukacs NW, Sunahara RK, Woods JH, Ko MC.

Neuropsychopharmacology. 2011 Apr;36(5):1047-59. doi: 10.1038/npp.2010.242. Epub 2011 Feb 2.

31.

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Collins GT, Truong YN, Levant B, Chen J, Wang S, Woods JH.

Psychopharmacology (Berl). 2011 Jun;215(4):609-20. doi: 10.1007/s00213-010-2154-7. Epub 2011 Jan 5.

32.

Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats.

Li SM, Collins GT, Paul NM, Grundt P, Newman AH, Xu M, Grandy DK, Woods JH, Katz JL.

Behav Pharmacol. 2010 May;21(3):171-81. doi: 10.1097/FBP.0b013e32833a5c68.

33.

Neurophamacology of yawning.

Collins GT, Eguibar JR.

Front Neurol Neurosci. 2010;28:90-106. doi: 10.1159/000307085. Epub 2010 Mar 26.

PMID:
20357467
34.

Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.

Collins GT, Brim RL, Narasimhan D, Ko MC, Sunahara RK, Zhan CG, Woods JH.

J Pharmacol Exp Ther. 2009 Nov;331(2):445-55. doi: 10.1124/jpet.108.150029. Epub 2009 Aug 26.

35.

Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats.

Collins GT, Woods JH.

Behav Pharmacol. 2009 Sep;20(5-6):492-504. doi: 10.1097/FBP.0b013e328330ad9b.

36.

Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.

Collins GT, Truccone A, Haji-Abdi F, Newman AH, Grundt P, Rice KC, Husbands SM, Greedy BM, Enguehard-Gueiffier C, Gueiffier A, Chen J, Wang S, Katz JL, Grandy DK, Sunahara RK, Woods JH.

J Pharmacol Exp Ther. 2009 Apr;329(1):210-7. doi: 10.1124/jpet.108.144048. Epub 2009 Jan 9.

37.

Narrowing in on compulsions: dopamine receptor functions.

Collins GT, Woods JH.

Exp Clin Psychopharmacol. 2008 Dec;16(6):498-502. doi: 10.1037/a0014190.

38.

Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.

Chen J, Collins GT, Zhang J, Yang CY, Levant B, Woods J, Wang S.

J Med Chem. 2008 Oct 9;51(19):5905-8. doi: 10.1021/jm800471h. Epub 2008 Sep 12.

39.
40.

Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat.

Collins GT, Woods JH.

J Pharmacol Exp Ther. 2007 Nov;323(2):599-605. Epub 2007 Aug 3.

41.

Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists.

Collins GT, Newman AH, Grundt P, Rice KC, Husbands SM, Chauvignac C, Chen J, Wang S, Woods JH.

Psychopharmacology (Berl). 2007 Aug;193(2):159-70. Epub 2007 Mar 29.

42.

Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.

Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH.

J Pharmacol Exp Ther. 2005 Jul;314(1):310-9. Epub 2005 Apr 15.

43.

Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study.

Parks RW, Becker RE, Rippey RF, Gilbert DG, Matthews JR, Kabatay E, Young CS, Vohs C, Danz V, Keim P, Collins GT, Zigler SS, Urycki PG.

Neuropsychol Rev. 1996 Jun;6(2):61-79. Review.

PMID:
8976498

Supplemental Content

Loading ...
Support Center